vs
Side-by-side financial comparison of Foghorn Therapeutics Inc. (FHTX) and PARK AEROSPACE CORP (PKE). Click either name above to swap in a different company.
PARK AEROSPACE CORP is the larger business by last-quarter revenue ($17.3M vs $9.2M, roughly 1.9× Foghorn Therapeutics Inc.). PARK AEROSPACE CORP runs the higher net margin — 17.0% vs -234.3%, a 251.3% gap on every dollar of revenue. On growth, Foghorn Therapeutics Inc. posted the faster year-over-year revenue change (223.8% vs 20.3%). Over the past eight quarters, Foghorn Therapeutics Inc.'s revenue compounded faster (35.3% CAGR vs 3.0%).
Foghorn Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing novel therapies targeting the chromatin regulatory system to treat various types of cancer and other severe diseases. It advances a diverse pipeline of targeted drug candidates, conducting internal R&D and strategic partnerships to serve global patient populations.
Park Electrochemical Corp, now called the Park Aerospace Corp, is a Melville, New York-based materials manufacturer for the telecommunications, Internet infrastructure, high-end computing, and aerospace industries. It produces high-technology digital and radio frequency(RF)/microwave printed circuit material products, composite materials. Its printed circuit materials are used for complex multilayer printed circuit boards and other electronic interconnection systems, such as multilayer back-p...
FHTX vs PKE — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $9.2M | $17.3M |
| Net Profit | $-21.7M | $3.0M |
| Gross Margin | — | 34.1% |
| Operating Margin | -258.2% | 21.0% |
| Net Margin | -234.3% | 17.0% |
| Revenue YoY | 223.8% | 20.3% |
| Net Profit YoY | -11.1% | 87.1% |
| EPS (diluted) | $-0.35 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $9.2M | $17.3M | ||
| Q3 25 | $8.2M | $16.4M | ||
| Q2 25 | $7.6M | $15.4M | ||
| Q1 25 | $6.0M | $16.9M | ||
| Q4 24 | $2.9M | $14.4M | ||
| Q3 24 | $7.8M | $16.7M | ||
| Q2 24 | $6.9M | $14.0M | ||
| Q1 24 | $5.0M | $16.3M |
| Q4 25 | $-21.7M | $3.0M | ||
| Q3 25 | $-15.8M | $2.4M | ||
| Q2 25 | $-17.9M | $2.1M | ||
| Q1 25 | $-18.8M | $1.2M | ||
| Q4 24 | $-19.5M | $1.6M | ||
| Q3 24 | $-19.1M | $2.1M | ||
| Q2 24 | $-23.0M | $993.0K | ||
| Q1 24 | $-25.0M | $2.7M |
| Q4 25 | — | 34.1% | ||
| Q3 25 | — | 31.2% | ||
| Q2 25 | — | 30.6% | ||
| Q1 25 | — | 29.3% | ||
| Q4 24 | — | 26.6% | ||
| Q3 24 | — | 28.5% | ||
| Q2 24 | — | 29.3% | ||
| Q1 24 | — | 27.3% |
| Q4 25 | -258.2% | 21.0% | ||
| Q3 25 | -226.9% | 17.4% | ||
| Q2 25 | -279.2% | 15.7% | ||
| Q1 25 | -385.0% | 16.8% | ||
| Q4 24 | -840.5% | 12.8% | ||
| Q3 24 | -305.5% | 15.7% | ||
| Q2 24 | -386.6% | 14.9% | ||
| Q1 24 | -558.3% | 15.7% |
| Q4 25 | -234.3% | 17.0% | ||
| Q3 25 | -194.4% | 14.7% | ||
| Q2 25 | -237.3% | 13.5% | ||
| Q1 25 | -316.4% | 7.4% | ||
| Q4 24 | -682.9% | 10.9% | ||
| Q3 24 | -244.9% | 12.4% | ||
| Q2 24 | -333.6% | 7.1% | ||
| Q1 24 | -495.4% | 16.3% |
| Q4 25 | $-0.35 | $0.15 | ||
| Q3 25 | $-0.25 | $0.12 | ||
| Q2 25 | $-0.28 | $0.10 | ||
| Q1 25 | $-0.30 | $0.06 | ||
| Q4 24 | $-0.23 | $0.08 | ||
| Q3 24 | $-0.31 | $0.10 | ||
| Q2 24 | $-0.45 | $0.05 | ||
| Q1 24 | $-0.59 | $0.13 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $80.9M | $63.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-108.5M | $106.6M |
| Total Assets | $198.1M | $118.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $80.9M | $63.6M | ||
| Q3 25 | $89.3M | $61.6M | ||
| Q2 25 | $72.6M | $65.6M | ||
| Q1 25 | $61.0M | $68.8M | ||
| Q4 24 | $55.5M | $70.0M | ||
| Q3 24 | $57.7M | $72.0M | ||
| Q2 24 | $138.9M | $74.4M | ||
| Q1 24 | $79.3M | $77.2M |
| Q4 25 | $-108.5M | $106.6M | ||
| Q3 25 | $-89.7M | $105.8M | ||
| Q2 25 | $-76.7M | $105.0M | ||
| Q1 25 | $-61.7M | $107.2M | ||
| Q4 24 | $-45.5M | $107.4M | ||
| Q3 24 | $-28.3M | $110.3M | ||
| Q2 24 | $-14.3M | $111.7M | ||
| Q1 24 | $-97.5M | $112.9M |
| Q4 25 | $198.1M | $118.1M | ||
| Q3 25 | $205.0M | $116.4M | ||
| Q2 25 | $226.2M | $120.7M | ||
| Q1 25 | $258.7M | $122.1M | ||
| Q4 24 | $284.0M | $124.2M | ||
| Q3 24 | $308.4M | $125.1M | ||
| Q2 24 | $328.6M | $129.4M | ||
| Q1 24 | $255.0M | $132.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-22.3M | $5.1M |
| Free Cash FlowOCF − Capex | — | $4.3M |
| FCF MarginFCF / Revenue | — | 24.6% |
| Capex IntensityCapex / Revenue | 0.0% | 4.8% |
| Cash ConversionOCF / Net Profit | — | 1.73× |
| TTM Free Cash FlowTrailing 4 quarters | — | $3.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-22.3M | $5.1M | ||
| Q3 25 | $-18.9M | $-2.1M | ||
| Q2 25 | $-21.0M | $1.6M | ||
| Q1 25 | $-24.0M | $969.0K | ||
| Q4 24 | $-24.5M | $2.7M | ||
| Q3 24 | $-21.0M | $1.4M | ||
| Q2 24 | $-25.5M | $-423.0K | ||
| Q1 24 | $-29.3M | $5.3M |
| Q4 25 | — | $4.3M | ||
| Q3 25 | — | $-2.3M | ||
| Q2 25 | $-21.0M | $1.1M | ||
| Q1 25 | $-24.0M | $338.0K | ||
| Q4 24 | $-25.0M | $2.7M | ||
| Q3 24 | $-21.3M | $1.3M | ||
| Q2 24 | $-25.6M | $-435.0K | ||
| Q1 24 | $-29.4M | $5.1M |
| Q4 25 | — | 24.6% | ||
| Q3 25 | — | -14.0% | ||
| Q2 25 | -278.2% | 7.2% | ||
| Q1 25 | -403.2% | 2.0% | ||
| Q4 24 | -875.3% | 18.6% | ||
| Q3 24 | -273.0% | 7.5% | ||
| Q2 24 | -371.0% | -3.1% | ||
| Q1 24 | -583.1% | 31.4% |
| Q4 25 | 0.0% | 4.8% | ||
| Q3 25 | 0.0% | 1.1% | ||
| Q2 25 | 0.3% | 3.1% | ||
| Q1 25 | 0.5% | 3.7% | ||
| Q4 24 | 16.8% | 0.4% | ||
| Q3 24 | 4.0% | 1.2% | ||
| Q2 24 | 0.2% | 0.1% | ||
| Q1 24 | 2.0% | 1.0% |
| Q4 25 | — | 1.73× | ||
| Q3 25 | — | -0.88× | ||
| Q2 25 | — | 0.76× | ||
| Q1 25 | — | 0.78× | ||
| Q4 24 | — | 1.73× | ||
| Q3 24 | — | 0.70× | ||
| Q2 24 | — | -0.43× | ||
| Q1 24 | — | 1.98× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FHTX
Segment breakdown not available.
PKE
| North America | $16.8M | 97% |
| Other | $546.0K | 3% |
